SPL 0.00% 8.9¢ starpharma holdings limited

Esmer, to me, this just broadens the potential application of...

  1. 2,834 Posts.
    lightbulb Created with Sketch. 138
    Esmer, to me, this just broadens the potential application of DEP technology to other oncology products. A positive, as it doesnt reduce other potential developments or licensing of the other DEP phase 2/3 products.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
8.9¢
Change
0.000(0.00%)
Mkt cap ! $36.67M
Open High Low Value Volume
9.0¢ 9.3¢ 8.9¢ $132.1K 1.454M

Buyers (Bids)

No. Vol. Price($)
3 121499 8.9¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 3000 1
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.